becton dickinson and co (BDX:New York)
Transactions by BECTON DICKINSON AND CO (BDX) in the last 6 months
Becton, Dickinson and Company (NYSE:BDX) acquired GenCell Biosystems Ltd. from Kieran Curran for $150 million on October 13, 2014. Jefferies LLC acted as a financial advisor to GenCell Biosystems Ltd. Donal O’Connell of Pegasus Capital acted as the financial advisor for GenCell.
Becton, Dickinson and Company (NYSE:BDX) entered into an agreement and plan of merger to acquire CareFusion Corporation (NYSE:CFN) from The Vanguard Group, Inc. and others for $11.8 billion in cash and stock on October 5, 2014.Under the terms, CareFusion shareholders will receive $49 in cash and 0.0777 of a share of Becton, Dickinson for each share of CareFusion. Upon closing, Becton, Dickinson shareholders will own approximately 92% of the combined company and CareFusion ...
Perella Weinberg Partners LP
|Agilent Technologies Inc||$42.21 USD||-0.15|
|Astellas Pharma Inc||¥1,901 JPY||+3.00|
|Illumina Inc||$195.46 USD||-3.00|
|Mylan Inc/PA||$57.33 USD||+0.08|
|Zimmer Holdings Inc||$120.39 USD||-0.94|
|View Industry Companies|